Therapeutic Nuclear Medicines Market Report

Global and Regional Therapeutic Nuclear Medicines Market Details Research Report 2021-2026

  • POSTDATE：Jul 05, 2021
  • PAGES：236
  • REPORT CODE：GMM756950
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Therapeutic Nuclear Medicines Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Therapeutic Nuclear Medicines market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Therapeutic Nuclear Medicines market.

    By Player:

    • Acrotech Biopharma, Progenics Pharmaceuticals

    • International Isotopes

    • Jubilant DraxImage

    • Q BioMed

    • Dongcheng

    • China Isotope & Radiation

    • Novartis AG

    • Bayer

    • Curium Pharmaceuticals

    • Lantheus

    By Type:

    • Radium-223

    • Lutetium-177

    • Iodine-131

    • Other

    By End-User:

    • Thyroid

    • Bone Metastasis

    • Lymphoma

    • Other

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Therapeutic Nuclear Medicines Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Therapeutic Nuclear Medicines Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Therapeutic Nuclear Medicines Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Therapeutic Nuclear Medicines Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Therapeutic Nuclear Medicines Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Therapeutic Nuclear Medicines Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Acrotech Biopharma, Progenics Pharmaceuticals

      • 3.1.1 Acrotech Biopharma, Progenics Pharmaceuticals - Company Business Overview

      • 3.1.2 Acrotech Biopharma, Progenics Pharmaceuticals - Company Financial Performance

      • 3.1.3 Acrotech Biopharma, Progenics Pharmaceuticals - Company Financial Performance of Therapeutic Nuclear Medicines

      • 3.1.4 Therapeutic Nuclear Medicines Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 International Isotopes

      • 3.2.1 International Isotopes - Company Business Overview

      • 3.2.2 International Isotopes - Company Financial Performance

      • 3.2.3 International Isotopes - Company Financial Performance of Therapeutic Nuclear Medicines

      • 3.2.4 Therapeutic Nuclear Medicines Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Jubilant DraxImage

      • 3.3.1 Jubilant DraxImage - Company Business Overview

      • 3.3.2 Jubilant DraxImage - Company Financial Performance

      • 3.3.3 Jubilant DraxImage - Company Financial Performance of Therapeutic Nuclear Medicines

      • 3.3.4 Therapeutic Nuclear Medicines Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Q BioMed

      • 3.4.1 Q BioMed - Company Business Overview

      • 3.4.2 Q BioMed - Company Financial Performance

      • 3.4.3 Q BioMed - Company Financial Performance of Therapeutic Nuclear Medicines

      • 3.4.4 Therapeutic Nuclear Medicines Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Dongcheng

      • 3.5.1 Dongcheng - Company Business Overview

      • 3.5.2 Dongcheng - Company Financial Performance

      • 3.5.3 Dongcheng - Company Financial Performance of Therapeutic Nuclear Medicines

      • 3.5.4 Therapeutic Nuclear Medicines Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 China Isotope & Radiation

      • 3.6.1 China Isotope & Radiation - Company Business Overview

      • 3.6.2 China Isotope & Radiation - Company Financial Performance

      • 3.6.3 China Isotope & Radiation - Company Financial Performance of Therapeutic Nuclear Medicines

      • 3.6.4 Therapeutic Nuclear Medicines Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Novartis AG

      • 3.7.1 Novartis AG - Company Business Overview

      • 3.7.2 Novartis AG - Company Financial Performance

      • 3.7.3 Novartis AG - Company Financial Performance of Therapeutic Nuclear Medicines

      • 3.7.4 Therapeutic Nuclear Medicines Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Bayer

      • 3.8.1 Bayer - Company Business Overview

      • 3.8.2 Bayer - Company Financial Performance

      • 3.8.3 Bayer - Company Financial Performance of Therapeutic Nuclear Medicines

      • 3.8.4 Therapeutic Nuclear Medicines Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Curium Pharmaceuticals

      • 3.9.1 Curium Pharmaceuticals - Company Business Overview

      • 3.9.2 Curium Pharmaceuticals - Company Financial Performance

      • 3.9.3 Curium Pharmaceuticals - Company Financial Performance of Therapeutic Nuclear Medicines

      • 3.9.4 Therapeutic Nuclear Medicines Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Lantheus

      • 3.10.1 Lantheus - Company Business Overview

      • 3.10.2 Lantheus - Company Financial Performance

      • 3.10.3 Lantheus - Company Financial Performance of Therapeutic Nuclear Medicines

      • 3.10.4 Therapeutic Nuclear Medicines Product Benchmarking

      • 3.10.5 Strategic Initiatives

    4 Global Therapeutic Nuclear Medicines Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Therapeutic Nuclear Medicines Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Radium-223 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Lutetium-177 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Iodine-131 2016-2021

      • 4.2.4 Global Revenue and Growth Rate of Other 2016-2021

    • 4.3 Global Therapeutic Nuclear Medicines Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Radium-223 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Lutetium-177 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Iodine-131 2016-2021

      • 4.3.4 Global Sales and Growth Rate of Other 2016-2021

    • 4.4 Global Therapeutic Nuclear Medicines Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Therapeutic Nuclear Medicines Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Therapeutic Nuclear Medicines Market Price By Type from 2016 to 2026

    5 Global Therapeutic Nuclear Medicines Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Therapeutic Nuclear Medicines

    • 5.2 Global Therapeutic Nuclear Medicines Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Thyroid 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Bone Metastasis 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Lymphoma 2016-2021

      • 5.2.4 Global Revenue and Growth Rate of Other 2016-2021

    • 5.3 Global Therapeutic Nuclear Medicines Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Thyroid 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Bone Metastasis 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Lymphoma 2016-2021

      • 5.3.4 Global Sales and Growth Rate of Other 2016-2021

    • 5.4 Global Therapeutic Nuclear Medicines Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Therapeutic Nuclear Medicines Market Sales and Market Share by Application (Forecast)

    6 Global Therapeutic Nuclear Medicines Market Segment Analysis (Geography Level)

    • 6.1 Global Therapeutic Nuclear Medicines Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Therapeutic Nuclear Medicines Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Therapeutic Nuclear Medicines Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Therapeutic Nuclear Medicines Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Therapeutic Nuclear Medicines Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Therapeutic Nuclear Medicines Market from 2016 to 2020

    7. North America Therapeutic Nuclear Medicines Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Therapeutic Nuclear Medicines Market Segment by Countries

      • 7.1.1 North America Therapeutic Nuclear Medicines Market Revenue Segment by Countries

      • 7.1.2 North America Therapeutic Nuclear Medicines Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Therapeutic Nuclear Medicines Market Segment (Product Type Level)

    • 7.3 North America Therapeutic Nuclear Medicines Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Therapeutic Nuclear Medicines Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Therapeutic Nuclear Medicines Market Segment by Countries

      • 8.1.1 Europe Therapeutic Nuclear Medicines Market Revenue Segment by Countries

      • 8.1.2 Europe Therapeutic Nuclear Medicines Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Therapeutic Nuclear Medicines Market Segment (Product Type Level)

    • 8.3 Europe Therapeutic Nuclear Medicines Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Therapeutic Nuclear Medicines Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Therapeutic Nuclear Medicines Market Segment by Countries

      • 9.1.1 Asia Therapeutic Nuclear Medicines Market Revenue Segment by Countries

      • 9.1.2 Asia Therapeutic Nuclear Medicines Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Therapeutic Nuclear Medicines Market Segment (Product Type Level)

    • 9.3 Asia Therapeutic Nuclear Medicines Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Therapeutic Nuclear Medicines Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Therapeutic Nuclear Medicines Market Segment by Countries

      • 10.1.1 South America Therapeutic Nuclear Medicines Market Revenue Segment by Countries

      • 10.1.2 South America Therapeutic Nuclear Medicines Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Therapeutic Nuclear Medicines Market Segment (Product Type Level)

    • 10.3 South America Therapeutic Nuclear Medicines Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Therapeutic Nuclear Medicines Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Therapeutic Nuclear Medicines Market Segment by Countries

      • 11.1.1 Middle East Therapeutic Nuclear Medicines Market Revenue Segment by Countries

      • 11.1.2 Middle East Therapeutic Nuclear Medicines Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Therapeutic Nuclear Medicines Market Segment (Product Type Level)

    • 11.3 Middle East Therapeutic Nuclear Medicines Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Therapeutic Nuclear Medicines Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Therapeutic Nuclear Medicines Market Segment by Countries

      • 12.1.1 Africa Therapeutic Nuclear Medicines Market Revenue Segment by Countries

      • 12.1.2 Africa Therapeutic Nuclear Medicines Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Therapeutic Nuclear Medicines Market Segment (Product Type Level)

    • 12.3 Africa Therapeutic Nuclear Medicines Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Therapeutic Nuclear Medicines Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Therapeutic Nuclear Medicines Market Segment by Countries

      • 13.1.1 Oceania Therapeutic Nuclear Medicines Market Revenue Segment by Countries

      • 13.1.2 Oceania Therapeutic Nuclear Medicines Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Therapeutic Nuclear Medicines Market Segment (Product Type Level)

    • 13.3 Oceania Therapeutic Nuclear Medicines Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Therapeutic Nuclear Medicines Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Therapeutic Nuclear Medicines

      • 14.2.2 Manufacturing Process Analysis of Therapeutic Nuclear Medicines

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Therapeutic Nuclear Medicines Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Therapeutic Nuclear Medicines Industry Market Status, Pre-COVID-19

      • 15.5.3 Therapeutic Nuclear Medicines Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Therapeutic Nuclear Medicines Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Therapeutic Nuclear Medicines Product Picture

    • Table Therapeutic Nuclear Medicines Product Definition

    • Table Study Scope by Types

    • Figure Global Therapeutic Nuclear Medicines Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Therapeutic Nuclear Medicines Market Value by Application (2016 - 2026)

    • Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate from 2016 to 2026

    • Table Global Therapeutic Nuclear Medicines Production Capacity by Manufacturers (2016-2021)

    • Table Global Therapeutic Nuclear Medicines Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2016-2021)

    • Table Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Therapeutic Nuclear Medicines Plant Distribution and Sales Country

    • Table Acrotech Biopharma, Progenics Pharmaceuticals - Company Business Overview

    • Figure Acrotech Biopharma, Progenics Pharmaceuticals Total Revenue from 2018 to 2020

    • Table Acrotech Biopharma, Progenics Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Acrotech Biopharma, Progenics Pharmaceuticals Sales and Growth Rate Analysis of Therapeutic Nuclear Medicines

    • Figure Revenue and Market Share Analysis of Acrotech Biopharma, Progenics Pharmaceuticals

    • Table Therapeutic Nuclear Medicines Product Benchmarking

    • Table International Isotopes - Company Business Overview

    • Figure International Isotopes Total Revenue from 2018 to 2020

    • Table International Isotopes Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure International Isotopes Sales and Growth Rate Analysis of Therapeutic Nuclear Medicines

    • Figure Revenue and Market Share Analysis of International Isotopes

    • Table Therapeutic Nuclear Medicines Product Benchmarking

    • Table Jubilant DraxImage - Company Business Overview

    • Figure Jubilant DraxImage Total Revenue from 2018 to 2020

    • Table Jubilant DraxImage Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Jubilant DraxImage Sales and Growth Rate Analysis of Therapeutic Nuclear Medicines

    • Figure Revenue and Market Share Analysis of Jubilant DraxImage

    • Table Therapeutic Nuclear Medicines Product Benchmarking

    • Table Q BioMed - Company Business Overview

    • Figure Q BioMed Total Revenue from 2018 to 2020

    • Table Q BioMed Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Q BioMed Sales and Growth Rate Analysis of Therapeutic Nuclear Medicines

    • Figure Revenue and Market Share Analysis of Q BioMed

    • Table Therapeutic Nuclear Medicines Product Benchmarking

    • Table Dongcheng - Company Business Overview

    • Figure Dongcheng Total Revenue from 2018 to 2020

    • Table Dongcheng Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Dongcheng Sales and Growth Rate Analysis of Therapeutic Nuclear Medicines

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Therapeutic Nuclear Medicines Product Benchmarking

    • Table China Isotope & Radiation - Company Business Overview

    • Figure China Isotope & Radiation Total Revenue from 2018 to 2020

    • Table China Isotope & Radiation Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure China Isotope & Radiation Sales and Growth Rate Analysis of Therapeutic Nuclear Medicines

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Therapeutic Nuclear Medicines Product Benchmarking

    • Table Novartis AG - Company Business Overview

    • Figure Novartis AG Total Revenue from 2018 to 2020

    • Table Novartis AG Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Novartis AG Sales and Growth Rate Analysis of Therapeutic Nuclear Medicines

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Therapeutic Nuclear Medicines Product Benchmarking

    • Table Bayer - Company Business Overview

    • Figure Bayer Total Revenue from 2018 to 2020

    • Table Bayer Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bayer Sales and Growth Rate Analysis of Therapeutic Nuclear Medicines

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Therapeutic Nuclear Medicines Product Benchmarking

    • Table Curium Pharmaceuticals - Company Business Overview

    • Figure Curium Pharmaceuticals Total Revenue from 2018 to 2020

    • Table Curium Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Curium Pharmaceuticals Sales and Growth Rate Analysis of Therapeutic Nuclear Medicines

    • Figure Revenue and Market Share Analysis of Curium Pharmaceuticals

    • Table Therapeutic Nuclear Medicines Product Benchmarking

    • Table Lantheus - Company Business Overview

    • Figure Lantheus Total Revenue from 2018 to 2020

    • Table Lantheus Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Lantheus Sales and Growth Rate Analysis of Therapeutic Nuclear Medicines

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Therapeutic Nuclear Medicines Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Therapeutic Nuclear Medicines Market Revenue by Types (Historical)

    • Table Global Therapeutic Nuclear Medicines Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Radium-223 2016-2021

    • Figure Global Revenue and Growth Rate of Lutetium-177 2016-2021

    • Figure Global Revenue and Growth Rate of Iodine-131 2016-2021

    • Figure Global Revenue and Growth Rate of Other 2016-2021

    • Table Global Therapeutic Nuclear Medicines Market Sales by Types (Historical)

    • Table Global Therapeutic Nuclear Medicines Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Radium-223 2016-2021

    • Figure Global Sales and Growth Rate of Lutetium-177 2016-2021

    • Figure Global Sales and Growth Rate of Iodine-131 2016-2021

    • Figure Global Sales and Growth Rate of Other 2016-2021

    • Table Global Therapeutic Nuclear Medicines Market Revenue by Types (Forecast)

    • Table Global Therapeutic Nuclear Medicines Market Revenue Market Share by Types (Forecast)

    • Table Global Therapeutic Nuclear Medicines Market Sales by Types (Forecast)

    • Table Global Therapeutic Nuclear Medicines Market Sales Market Share by Types (Forecast)

    • Figure Global Therapeutic Nuclear Medicines Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Therapeutic Nuclear Medicines

    • Table Global Therapeutic Nuclear Medicines Market Revenue by Application (Historical)

    • Table Global Therapeutic Nuclear Medicines Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Thyroid 2016-2021

    • Figure Global Revenue and Growth Rate of Bone Metastasis 2016-2021

    • Figure Global Revenue and Growth Rate of Lymphoma 2016-2021

    • Figure Global Revenue and Growth Rate of Other 2016-2021

    • Table Global Therapeutic Nuclear Medicines Market Sales by Application (Historical)

    • Table Global Therapeutic Nuclear Medicines Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Thyroid 2016-2021

    • Figure Global Sales and Growth Rate of Bone Metastasis 2016-2021

    • Figure Global Sales and Growth Rate of Lymphoma 2016-2021

    • Figure Global Sales and Growth Rate of Other 2016-2021

    • Table Global Therapeutic Nuclear Medicines Market Revenue by Application (Forecast)

    • Table Global Therapeutic Nuclear Medicines Market Revenue Market Share by Application (Forecast)

    • Table Global Therapeutic Nuclear Medicines Market Sales by Application (Forecast)

    • Table Global Therapeutic Nuclear Medicines Market Sales Market Share by Application (Forecast)

    • Table Global Therapeutic Nuclear Medicines Market Revenue by Geography (Historical)

    • Table Global Therapeutic Nuclear Medicines Market Revenue Market Share by Geography (Historical)

    • Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Geography in 2020

    • Table Global Therapeutic Nuclear Medicines Market Sales by Geography (Historical)

    • Table Global Therapeutic Nuclear Medicines Market Sales Market Share by Geography (Historical)

    • Figure Global Therapeutic Nuclear Medicines Sales Market Share by Geography in 2020

    • Table Global Therapeutic Nuclear Medicines Market Revenue by Geography (Forecast)

    • Table Global Therapeutic Nuclear Medicines Market Revenue Market Share by Geography (Forecast)

    • Table Global Therapeutic Nuclear Medicines Market Sales by Geography (Forecast)

    • Table Global Therapeutic Nuclear Medicines Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Therapeutic Nuclear Medicines Revenue by Countries from 2016 to 2026

    • Table North America Therapeutic Nuclear Medicines Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Therapeutic Nuclear Medicines Revenue Market Share by Major Countries in 2020

    • Table North America Therapeutic Nuclear Medicines Sales by Countries from 2016 to 2026

    • Table North America Therapeutic Nuclear Medicines Sales Market Share by Countries from 2016 to 2026

    • Figure North America Therapeutic Nuclear Medicines Sales Market Share by Major Countries in 2020

    • Figure USA Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure USA Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Table North America Therapeutic Nuclear Medicines Sales by Types from 2016 to 2026

    • Table North America Therapeutic Nuclear Medicines Sales Market Share by Types from 2016 to 2026

    • Table North America Therapeutic Nuclear Medicines Value by Types from 2016 to 2026

    • Table North America Therapeutic Nuclear Medicines Value Market Share by Types from 2016 to 2026

    • Table North America Therapeutic Nuclear Medicines Sales by Application from 2016 to 2026

    • Table North America Therapeutic Nuclear Medicines Sales Market Share by Application from 2016 to 2026

    • Table North America Therapeutic Nuclear Medicines Value by Application from 2016 to 2026

    • Table North America Therapeutic Nuclear Medicines Value Market Share by Application from 2016 to 2026

    • Table Europe Therapeutic Nuclear Medicines Revenue by Countries from 2016 to 2026

    • Table Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Therapeutic Nuclear Medicines Revenue Market Share by Major Countries in 2020

    • Table Europe Therapeutic Nuclear Medicines Sales by Countries from 2016 to 2026

    • Table Europe Therapeutic Nuclear Medicines Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Therapeutic Nuclear Medicines Sales Market Share by Major Countries in 2020

    • Figure Germany Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure France Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure France Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Others Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Therapeutic Nuclear Medicines Sales by Types from 2016 to 2026

    • Table Europe Therapeutic Nuclear Medicines Sales Market Share by Types from 2016 to 2026

    • Table Europe Therapeutic Nuclear Medicines Value by Types from 2016 to 2026

    • Table Europe Therapeutic Nuclear Medicines Value Market Share by Types from 2016 to 2026

    • Table Europe Therapeutic Nuclear Medicines Sales by Application from 2016 to 2026

    • Table Europe Therapeutic Nuclear Medicines Sales Market Share by Application from 2016 to 2026

    • Table Europe Therapeutic Nuclear Medicines Value by Application from 2016 to 2026

    • Table Europe Therapeutic Nuclear Medicines Value Market Share by Application from 2016 to 2026

    • Table Asia Therapeutic Nuclear Medicines Revenue by Countries from 2016 to 2026

    • Table Asia Therapeutic Nuclear Medicines Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Therapeutic Nuclear Medicines Revenue Market Share by Major Countries in 2020

    • Table Asia Therapeutic Nuclear Medicines Sales by Countries from 2016 to 2026

    • Table Asia Therapeutic Nuclear Medicines Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Therapeutic Nuclear Medicines Sales Market Share by Major Countries in 2020

    • Figure China Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure China Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure India Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure India Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Others Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Therapeutic Nuclear Medicines Sales by Types from 2016 to 2026

    • Table Asia Therapeutic Nuclear Medicines Sales Market Share by Types from 2016 to 2026

    • Table Asia Therapeutic Nuclear Medicines Value by Types from 2016 to 2026

    • Table Asia Therapeutic Nuclear Medicines Value Market Share by Types from 2016 to 2026

    • Table Asia Therapeutic Nuclear Medicines Sales by Application from 2016 to 2026

    • Table Asia Therapeutic Nuclear Medicines Sales Market Share by Application from 2016 to 2026

    • Table Asia Therapeutic Nuclear Medicines Value by Application from 2016 to 2026

    • Table Asia Therapeutic Nuclear Medicines Value Market Share by Application from 2016 to 2026

    • Table South America Therapeutic Nuclear Medicines Revenue by Countries from 2016 to 2026

    • Table South America Therapeutic Nuclear Medicines Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Therapeutic Nuclear Medicines Revenue Market Share by Major Countries in 2020

    • Table South America Therapeutic Nuclear Medicines Sales by Countries from 2016 to 2026

    • Table South America Therapeutic Nuclear Medicines Sales Market Share by Countries from 2016 to 2026

    • Figure South America Therapeutic Nuclear Medicines Sales Market Share by Major Countries in 2020

    • Figure Brazil Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Others Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Table South America Therapeutic Nuclear Medicines Sales by Types from 2016 to 2026

    • Table South America Therapeutic Nuclear Medicines Sales Market Share by Types from 2016 to 2026

    • Table South America Therapeutic Nuclear Medicines Value by Types from 2016 to 2026

    • Table South America Therapeutic Nuclear Medicines Value Market Share by Types from 2016 to 2026

    • Table South America Therapeutic Nuclear Medicines Sales by Application from 2016 to 2026

    • Table South America Therapeutic Nuclear Medicines Sales Market Share by Application from 2016 to 2026

    • Table South America Therapeutic Nuclear Medicines Value by Application from 2016 to 2026

    • Table South America Therapeutic Nuclear Medicines Value Market Share by Application from 2016 to 2026

    • Table Middle East Therapeutic Nuclear Medicines Revenue by Countries from 2016 to 2026

    • Table Middle East Therapeutic Nuclear Medicines Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Therapeutic Nuclear Medicines Revenue Market Share by Major Countries in 2020

    • Table Middle East Therapeutic Nuclear Medicines Sales by Countries from 2016 to 2026

    • Table Middle East Therapeutic Nuclear Medicines Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Therapeutic Nuclear Medicines Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Others Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Therapeutic Nuclear Medicines Sales by Types from 2016 to 2026

    • Table Middle East Therapeutic Nuclear Medicines Sales Market Share by Types from 2016 to 2026

    • Table Middle East Therapeutic Nuclear Medicines Value by Types from 2016 to 2026

    • Table Middle East Therapeutic Nuclear Medicines Value Market Share by Types from 2016 to 2026

    • Table Middle East Therapeutic Nuclear Medicines Sales by Application from 2016 to 2026

    • Table Middle East Therapeutic Nuclear Medicines Sales Market Share by Application from 2016 to 2026

    • Table Middle East Therapeutic Nuclear Medicines Value by Application from 2016 to 2026

    • Table Middle East Therapeutic Nuclear Medicines Value Market Share by Application from 2016 to 2026

    • Table Africa Therapeutic Nuclear Medicines Revenue by Countries from 2016 to 2026

    • Table Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Therapeutic Nuclear Medicines Revenue Market Share by Major Countries in 2020

    • Table Africa Therapeutic Nuclear Medicines Sales by Countries from 2016 to 2026

    • Table Africa Therapeutic Nuclear Medicines Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Major Countries in 2020

    • Figure Nigeria Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Others Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Therapeutic Nuclear Medicines Sales by Types from 2016 to 2026

    • Table Africa Therapeutic Nuclear Medicines Sales Market Share by Types from 2016 to 2026

    • Table Africa Therapeutic Nuclear Medicines Value by Types from 2016 to 2026

    • Table Africa Therapeutic Nuclear Medicines Value Market Share by Types from 2016 to 2026

    • Table Africa Therapeutic Nuclear Medicines Sales by Application from 2016 to 2026

    • Table Africa Therapeutic Nuclear Medicines Sales Market Share by Application from 2016 to 2026

    • Table Africa Therapeutic Nuclear Medicines Value by Application from 2016 to 2026

    • Table Africa Therapeutic Nuclear Medicines Value Market Share by Application from 2016 to 2026

    • Table Oceania Therapeutic Nuclear Medicines Revenue by Countries from 2016 to 2026

    • Table Oceania Therapeutic Nuclear Medicines Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Therapeutic Nuclear Medicines Revenue Market Share by Major Countries in 2020

    • Table Oceania Therapeutic Nuclear Medicines Sales by Countries from 2016 to 2026

    • Table Oceania Therapeutic Nuclear Medicines Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Therapeutic Nuclear Medicines Sales Market Share by Major Countries in 2020

    • Figure Australia Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Therapeutic Nuclear Medicines Market Value and Growth Rate from 2016 to 2026

    • Figure Others Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Therapeutic Nuclear Medicines Sales by Types from 2016 to 2026

    • Table Oceania Therapeutic Nuclear Medicines Sales Market Share by Types from 2016 to 2026

    • Table Oceania Therapeutic Nuclear Medicines Value by Types from 2016 to 2026

    • Table Oceania Therapeutic Nuclear Medicines Value Market Share by Types from 2016 to 2026

    • Table Oceania Therapeutic Nuclear Medicines Sales by Application from 2016 to 2026

    • Table Oceania Therapeutic Nuclear Medicines Sales Market Share by Application from 2016 to 2026

    • Table Oceania Therapeutic Nuclear Medicines Value by Application from 2016 to 2026

    • Table Oceania Therapeutic Nuclear Medicines Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Therapeutic Nuclear Medicines

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Therapeutic Nuclear Medicines with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US